Efficacy and Safety of Ferric Citrate on Hyperphosphatemia among Chinese Patients with Chronic Kidney Disease Undergoing Hemodialysis: A Phase III Multicenter Randomized Open-Label Active-Drug-Controlled Study.
Wang Y, Chen X, Zhu H, Guo Z, Yang Y, Luo P, He Y, Xu Y, Ji D, Gao X, Sun X, Xing C, Wang Y, Wang X, Zhao S, Guan Y, Lin H, Zhong A, Shui H, Shao F, Lv L, Yan Y, Sun X, Zhang L.
Wang Y, et al. Among authors: shui h.
Am J Nephrol. 2023;54(11-12):479-488. doi: 10.1159/000534484. Epub 2023 Oct 9.
Am J Nephrol. 2023.
PMID: 37812931
Clinical Trial.